Determination of anticoagulant rodenticides in faeces of exposed dogs and in a healthy dog population.
Brodifacoum
Bromadiolone
Canine
Difenacoum
Intoxication
Non-target animal
Rodenticide
Journal
Acta veterinaria Scandinavica
ISSN: 1751-0147
Titre abrégé: Acta Vet Scand
Pays: England
ID NLM: 0370400
Informations de publication
Date de publication:
16 Jun 2020
16 Jun 2020
Historique:
received:
23
04
2020
accepted:
12
06
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
23
10
2020
Statut:
epublish
Résumé
Exposure to anticoagulant rodenticides (ARs) in dogs is among the most common causes of poisoning in small animal practice, but information about toxicokinetic of these rodenticides in dogs is lacking. We analysed blood and faeces from five accidentally exposed dogs and 110 healthy dogs by reversed phase ultra-high performance liquid chromatography-tandem mass spectrometry. The aim of the study was to estimate elimination of brodifacoum, bromadiolone and difenacoum after acute exposure, calculate the half-lives of these rodenticides in dogs, estimate faecal elimination in a litter of puppies born, and further to identify the extent of AR exposure in a healthy dog population. Three dogs were included after single ingestions of brodifacoum; two dogs ingested bromadiolone and one dog ingested difenacoum. Maximum concentrations in faeces were found after day 2-3 for all ARs. The distribution half-lives were 1-10 days for brodifacoum, 1-2 days for bromadiolone and 10 days for difenacoum. Brodifacoum and difenacoum had estimated terminal half-lives of 200-330 days and 190 days, respectively. In contrast, bromadiolone had an estimated terminal half-life of 30 days. No clinical signs of poisoning or coagulopathy were observed in terminal elimination period. In blood, the terminal half-life of brodifacoum was estimated to 8 days. Faeces from a litter of puppies born from one of the poisoned dogs were examined, and measurable concentrations of brodifacoum were detected in all samples for at least 28 days after parturition. A cross-sectional study of 110 healthy domestic dogs was performed to estimate ARs exposure in a dog population. Difenacoum was detected in faeces of one dog. Blood and faecal samples from the remaining dogs were negative for all ARs. Based on the limited pharmacokinetic data from these dogs, our results suggest that ARs have a biphasic elimination in faeces using a two-compartment elimination kinetics model. We have shown that faecal analysis is suitable and reliable for the assessment of ARs exposure in dogs and a tool for estimating the AR half-lives. Half-lives of ARs could be a valuable indicator in the exposed dogs and provides important information for veterinarians monitoring AR exposure and assessment of treatment length in dogs.
Sections du résumé
BACKGROUND
BACKGROUND
Exposure to anticoagulant rodenticides (ARs) in dogs is among the most common causes of poisoning in small animal practice, but information about toxicokinetic of these rodenticides in dogs is lacking. We analysed blood and faeces from five accidentally exposed dogs and 110 healthy dogs by reversed phase ultra-high performance liquid chromatography-tandem mass spectrometry. The aim of the study was to estimate elimination of brodifacoum, bromadiolone and difenacoum after acute exposure, calculate the half-lives of these rodenticides in dogs, estimate faecal elimination in a litter of puppies born, and further to identify the extent of AR exposure in a healthy dog population.
RESULTS
RESULTS
Three dogs were included after single ingestions of brodifacoum; two dogs ingested bromadiolone and one dog ingested difenacoum. Maximum concentrations in faeces were found after day 2-3 for all ARs. The distribution half-lives were 1-10 days for brodifacoum, 1-2 days for bromadiolone and 10 days for difenacoum. Brodifacoum and difenacoum had estimated terminal half-lives of 200-330 days and 190 days, respectively. In contrast, bromadiolone had an estimated terminal half-life of 30 days. No clinical signs of poisoning or coagulopathy were observed in terminal elimination period. In blood, the terminal half-life of brodifacoum was estimated to 8 days. Faeces from a litter of puppies born from one of the poisoned dogs were examined, and measurable concentrations of brodifacoum were detected in all samples for at least 28 days after parturition. A cross-sectional study of 110 healthy domestic dogs was performed to estimate ARs exposure in a dog population. Difenacoum was detected in faeces of one dog. Blood and faecal samples from the remaining dogs were negative for all ARs.
CONCLUSIONS
CONCLUSIONS
Based on the limited pharmacokinetic data from these dogs, our results suggest that ARs have a biphasic elimination in faeces using a two-compartment elimination kinetics model. We have shown that faecal analysis is suitable and reliable for the assessment of ARs exposure in dogs and a tool for estimating the AR half-lives. Half-lives of ARs could be a valuable indicator in the exposed dogs and provides important information for veterinarians monitoring AR exposure and assessment of treatment length in dogs.
Identifiants
pubmed: 32546243
doi: 10.1186/s13028-020-00531-5
pii: 10.1186/s13028-020-00531-5
pmc: PMC7296905
doi:
Substances chimiques
4-Hydroxycoumarins
0
Anticoagulants
0
Rodenticides
0
bromfenacoum
A25P3CP5S7
bromadiolone
J2FR050NM5
difenacoum
SBA3K9U26B
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Subventions
Organisme : Agria Djurförsäkring (SE)
ID : N2017-011
Références
Clin Toxicol (Phila). 2008 Sep;46(8):703-10
pubmed: 19238731
Br J Pharmacol. 1985 Jan;84(1):81-91
pubmed: 3978316
Toxicol Rev. 2005;24(4):259-69
pubmed: 16499407
PLoS One. 2012;7(7):e40163
pubmed: 22808110
Comp Biochem Physiol B Biochem Mol Biol. 2005 Mar;140(3):465-73
pubmed: 15694595
Acta Vet Scand. 2018 Jan 17;60(1):3
pubmed: 29343296
Comp Biochem Physiol C Toxicol Pharmacol. 2010 Jun;152(1):114-9
pubmed: 20346414
Vet Q. 1998 Jan;20(1):24-7
pubmed: 9477532
Sci Total Environ. 2016 Jan 1;539:331-336
pubmed: 26367188
Chest. 2001 Jan;119(1 Suppl):8S-21S
pubmed: 11157640
J Vet Pharmacol Ther. 2008 Oct;31(5):437-45
pubmed: 19000263
Am J Vet Res. 1989 Apr;50(4):546-50
pubmed: 2712421
J Vet Diagn Invest. 2020 Jun 1;:1040638720927365
pubmed: 32476615
Xenobiotica. 1988 Dec;18(12):1465-79
pubmed: 3245237
Environ Res. 2010 Oct;110(7):664-74
pubmed: 20692656
Sci Total Environ. 2011 May 15;409(12):2373-8
pubmed: 21477845
Br J Haematol. 1963 Oct;9:506-12
pubmed: 14076133
Vet Pathol. 2003 Mar;40(2):216-9
pubmed: 12637764
J Vet Diagn Invest. 2018 Jan;30(1):169-171
pubmed: 29145778
Pest Manag Sci. 2017 Feb;73(2):364-370
pubmed: 27616006
Xenobiotica. 1989 Jan;19(1):51-62
pubmed: 2756717
Vet Clin North Am Small Anim Pract. 2018 Nov;48(6):1027-1038
pubmed: 30173927
Sci Rep. 2018 May 25;8(1):8168
pubmed: 29802369
J Vet Intern Med. 1992 Jan-Feb;6(1):23-8
pubmed: 1548622
Sci Total Environ. 2009 Dec 20;408(2):267-71
pubmed: 19863999
Mol Ecol. 2018 Mar;27(5):1170-1187
pubmed: 29427407